FDA Releases Guidance on Quality Considerations for Inhalers

The GMP Letter
A A
The FDA published draft guidance on metered dose and dry powder inhalers highlighting considerations for critical quality attributes.

To View This Article:

Login

Subscribe To The GMP Letter